Swiss Stock Market Mixed; Nestlé, Novartis, Roche Gain on Speculation, Deals
The Swiss stock market experienced a mixed day of trading, with both gains and losses among major players. The SMI, Switzerland's leading index, closed 0.86 percent higher at 12,109.42 points, while the SLI and SPI also saw modest increases. Nestlé led the gains, climbing 1.4 percent on speculation surrounding the potential sale of its water business. Meanwhile, pharmaceutical giants Novartis and Roche both benefited from positive news regarding a potential deal between the US and Pfizer on Most Favored Nation (MFN) pricing, closing 1.2 and 0.9 percent higher, respectively. On the downside, Kuehne + Nagel suffered a 2.2 percent loss, while Straumann and Sonova faced significant pressure, with Straumann dropping 2.7 percent. UBS shares, despite initial gains, ended the day 0.1 percent lower. Amrize, however, stood out as the top performer in the SLI, continuing its recovery path with a notable increase. The market closed firmer with a positive quarterly balance, despite the mixed performance of individual stocks. The SMI, SLI, and SPI all ended the day higher, reflecting overall optimism in the market.
Read also:
- Unveiling the Less-Discussed Disadvantages of Buds - Revealing the Silent Story
- Grid Risk Evaluation Strategy By NERC Outlined, Focusing on Potential Threats from Data Centers
- Rapid Expansion in Organic Rice Protein Market Projected at 15.6% Through 2034
- The Virtual Commissioning Market is projected to exceed $4.86 billion by the year 2034.
